Nina Kadášová

Nina Kadášová

Auto-generated profile, based on publicly available information

Nina Kadášová

Palacký University Olomouc

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2025 in bioRxiv
Verified
Preprint
Open access
AŠAnna Špačková
Anna Špačková
NKNina Kadášová
Nina Kadášová
IVIvana HutařOvá VařEková
Ivana HutařOvá VařEková
KBKarel Berka
Karel Berka
Motivation: Cytochrome P450 proteins play a crucial role in human metabolism, from the production of hormones to drug metabolism. While multiple commonly known variants have known effects on the individual cytochrome P450 protein performance, the pathogenicity information is usually experimentally limited to only a few mutations. Current pathogenicity prediction software allows one to extend the scope to virtually mutate all amino acids with missense mutations. In this work, we do a comprehensive exploration that unveils pathogenicity patterns in the human cytochrome P450 family. Pathogenicity analysis was conducted across proteins using SIFT and AlphaMissense algorithms. Results: Our findings indicate a progressive increase in pathogenicity along protein tunnels-identified via MOLE-toward the cofactor binding site, underscoring the essential role of cofactor interactions in enzymatic function. Notably, tunnel integrity emerges as a critical factor, with even single amino acid alterations potentially disrupting molecular guidance to active sites. These insights highlight the fundamental role of structural pathways in preserving cytochrome P450 functionality, with implications for understanding disease-associated variants and drug metabolism. Availability: Data and source code can be found at https://github.com/annaspac/P450_pathogenicity_codes Contact: anna.spackova@upol.cz , karel.berka@upol.cz

18 June 2026 in EP Europace
Verified
Journal Article
Open access
MKMartin Král
Martin Král
OŠOlga Švecová
Olga Švecová
RKRoman Kula
Roman Kula
NKNina Kadášová
Nina Kadášová
JLJindřIch Lněnička
JindřIch Lněnička
MBMarkéta Bébarová
Markéta Bébarová
Aims: Kv7.1 variants, associated with long QT syndrome type 1 (LQT1) and altering the function of the slow delayed rectifier K+ (IKs) channel, may result in arrhythmias, especially during exercise. This study focused on complex analysis of the R562S-Kv7.1 variant located in helix C of the Kv7.1 C terminus, which was identified in four putatively unrelated families in the Czech Republic. Methods and results: The clinical and genetic investigation was followed by functional analysis (whole-cell patch clamp, confocal microscopy, computational simulations) and structural modelling. The genetic analysis suggested that R562S-Kv7.1 might be a founder LQT1 variant in Central Europe. R562S carriers showed a significantly prolonged corrected QT (QTc) interval at rest and a significantly higher QTc prolongation after exercise vs. healthy relatives. The functional analysis of R562S channels demonstrated their preserved membrane localization, a significant decrease in IKs with a rightward shift of the voltage dependence of activation, and, importantly, a lack of responsiveness to β-adrenergic stimulation. The latter seems to be related to a modified interaction of the modulatory KCNE1 subunit with Kv7.1. The pro-arrhythmic potential of R562S dysfunction, mediated by delayed afterdepolarizations during β-adrenergic stimulation, could be effectively prevented by mild (5%) inhibition of L-type Ca2+ current (ICa). Conclusion: R562S-Kv7.1 is the first variant in helix C causing an impaired response of IKs channel to β-adrenergic stimulation, likely due to altered interactions between channel subunits, namely Kv7.1 and KCNE1. Mild ICa inhibition was suggested as a new treatment option.

2 July 2026 in bioRxiv
Verified
Preprint
Open access
NKNina Kadasova
Nina Kadasova
DMDominik Martinat
Dominik Martinat
ASAnna Spackova
Anna Spackova
IVIvana Hutarova Varekova
Ivana Hutarova Varekova
KBKarel Berka
Karel Berka
Significance Missense mutations can lead to pathological effects in human cells. Predictive methods that account for structural context, such as AlphaMissense, can provide pathogenicity scores. The accumulation of pathogenicity hotspots can reveal important structural features within individual proteins of protein families, such as GLUT transporters. Mapping pathogenicity scores onto the structure can thus provide a mechanistic explanation of the protein function necessary for its role in the cell. Abstract Non-synonymous amino acid substitutions (missense mutations) are common in the general population; some are causative of serious disease. Depending on their structural context, they can disrupt protein function, folding, or dynamics. Computational predictive methods developed in recent years, such as AlphaMissense, provide new insights into how missense mutations affect protein structure by predicting and mapping their pathogenicity across each amino acid in the human proteome. In this study, we identify recurring patterns of pathogenicity prediction across the GLUT family membrane transporters encoded by genes slc2a1-14. Within the GLUT transporter family, we observe higher pathogenicity profiles in the transmembrane domains, particularly in pore-lining and binding-site residues. Predicted missense pathogenicity is elevated throughout residues assigned to the central cavity, suggesting sensitivity of the transport pathway. Another finding shows higher pathogenicity in specific transmembrane helices of the protein, with the same pattern across all proteins. On the other hand, we observed lower pathogenicity values in some representatives of the GLUT family. These findings show that the pathogenicity of glucose transport within the GLUT family may be shaped by functional redundancy and physiological essentiality across GLUT groups.